Based in Japan and India. Has led to 1 successful fundraise in Japan. Been working the space of Venture Capital and Private Equity for the last 3 years.

Seattle tech startup BloomAPI aims to modernize medical records business and dig doctor’s offices out of the mountains of paperwork.

Most medical records are still transmitted between physicians using fax machines and snail mail.

This process is slow and error-prone, and almost half of the records requested never reach the doctor who needs them. It’s so inefficient that the US health care system is spending $2 Five billion a year for the transfer of records, the bill ultimately passed on to patients and taxpayers

BloomAPI automates this manual process by enabling medical computer systems-some of which were created in the 1990s-to communicate with each other, creating a network of physicians who can digitally share health records.

BloomAPI software can be installed in the doctor’s office in a matter of minutes. Once there, it connects to their electronic medical record system, pulls the requested record and sends it instantly to a patient, another doctor, or insurance company.

When connected to BloomAPI, a doctor no longer needs to worry about lost faxes, and they can get the information they need in an instant. BloomAPI already has 300 doctors in its network and is helping to digitally transmit records to more than 1,000,000 patients.

BloomAPI has just raised $2 4 million from Y-Combinator, Slow Ventures, Founders’ Co-Op, Bill Maris’ new fund, Section 32, Liquid 2 Ventures and Parker Conrad, among others, to solve this problem. This money will be used to hire a Seattle-based team of engineering, operations and sales staff to replace the arcane process of faxing and printing medical records.

Please note that this piece of work originally appeared in English at https://www.vcnewsdaily.com/BloomAPI/venture-funding.php. As Investocracy aims to bring global startup news and updates in both English and Japanese to you, it’s important that we attribute original source to you. If you have any questions/concerns please write to us at contact@investocracy.co

Leave a Reply

Your email address will not be published. Required fields are marked *